Company intelligence / Profile preview

Okava Pharmaceuticals

San Francisco, California, United Statesokava.com ↗

Ownership: Private
Employees: ~4
Development stage: Clinical

Overview

Okava is a clinical-stage biotech developing reformulated FDA-approved human drugs for veterinary use, focusing on chronic diseases of aging in dogs and cats. Its lead programs include a modified-release mycophenolate for immune-mediated hemolytic anemia and an ultra long-lasting GLP‑1 agonist implant for metabolic health. The company has received positive regulatory feedback from the FDA’s Center for Veterinary Medicine and is advancing multiple candidates toward pivotal studies

Therapeutic areas: Metabolic DisordersEndocrinologyImmunologyHematology
Modalities: Small moleculeBiologicDrug-device combination (implant)
Industry: Veterinary

Drug pipeline

1 asset

OKV-119

Clinical

Indications: Obesity, Diabetes, Metabolic disorders

Partnerships

Vivani Medical/Nano Precision Medical – collaboration on NanoPortal™ drug delivery platform for long-term GLP‑1 implants

Beyond the preview

Go deeper on Okava Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Okava Pharmaceuticals.

Explore the full profile